{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017736",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017736_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"adalimumab\" outputclass=\"int-drug\">adalimumab</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  adalimumab  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Adalimumab</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017737",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017737_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"alcohol\" outputclass=\"int-drug\">alcohol</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  alcohol  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Alcohol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017738",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017738_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"aldesleukin\" outputclass=\"int-drug\">aldesleukin</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  aldesleukin  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Aldesleukin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017739",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017739_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"alectinib\" outputclass=\"int-drug\">alectinib</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  alectinib  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Alectinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017740",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017740_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"alemtuzumab\" outputclass=\"int-drug\">alemtuzumab</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  alemtuzumab  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Alemtuzumab</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017741",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017741_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"amsacrine\" outputclass=\"int-drug\">amsacrine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  amsacrine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amsacrine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017742",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017742_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"arsenic trioxide\" outputclass=\"int-drug\">arsenic trioxide</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  arsenic trioxide  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Arsenic trioxide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017743",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017743_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"asparaginase\" outputclass=\"int-drug\">asparaginase</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  asparaginase  can increase the risk of hepatotoxicity. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017743_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"asparaginase\" outputclass=\"int-drug\">asparaginase</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  sulfasalazine  and  asparaginase  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Asparaginase</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017744",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017744_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"atorvastatin\" outputclass=\"int-drug\">atorvastatin</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  atorvastatin  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Atorvastatin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017745",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017745_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"axitinib\" outputclass=\"int-drug\">axitinib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  axitinib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Axitinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017746",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017746_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"azacitidine\" outputclass=\"int-drug\">azacitidine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  azacitidine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Azacitidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017747",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017747_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"azathioprine\" outputclass=\"int-drug\">azathioprine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  azathioprine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Azathioprine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017748",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017748_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"bedaquiline\" outputclass=\"int-drug\">bedaquiline</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  bedaquiline  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "13",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bedaquiline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017749",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017749_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"belatacept\" outputclass=\"int-drug\">belatacept</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  belatacept  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "14",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Belatacept</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017750",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017750_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"bendamustine\" outputclass=\"int-drug\">bendamustine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  bendamustine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "15",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bendamustine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017751",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017751_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"bevacizumab\" outputclass=\"int-drug\">bevacizumab</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  bevacizumab  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "16",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bevacizumab</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017752",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017752_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"bexarotene\" outputclass=\"int-drug\">bexarotene</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  bexarotene  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "17",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bexarotene</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017753",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017753_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"bleomycin\" outputclass=\"int-drug\">bleomycin</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  bleomycin  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "18",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bleomycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017754",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017754_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"blinatumomab\" outputclass=\"int-drug\">blinatumomab</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  blinatumomab  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "19",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Blinatumomab</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017755",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017755_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"bortezomib\" outputclass=\"int-drug\">bortezomib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  bortezomib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "20",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bortezomib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017756",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017756_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"bosutinib\" outputclass=\"int-drug\">bosutinib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  bosutinib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "21",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bosutinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017757",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017757_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"brentuximab vedotin\" outputclass=\"int-drug\">brentuximab vedotin</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  brentuximab vedotin  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "22",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Brentuximab vedotin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017758",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017758_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"busulfan\" outputclass=\"int-drug\">busulfan</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  busulfan  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "23",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Busulfan</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017759",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017759_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"cabazitaxel\" outputclass=\"int-drug\">cabazitaxel</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  cabazitaxel  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "24",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cabazitaxel</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017760",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017760_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"cabozantinib\" outputclass=\"int-drug\">cabozantinib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  cabozantinib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "25",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cabozantinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017761",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017761_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"canakinumab\" outputclass=\"int-drug\">canakinumab</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  canakinumab  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "26",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Canakinumab</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017762",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017762_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"capecitabine\" outputclass=\"int-drug\">capecitabine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  capecitabine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "27",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Capecitabine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017763",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017763_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"carbamazepine\" outputclass=\"int-drug\">carbamazepine</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  carbamazepine  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "28",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Carbamazepine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017764",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017764_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"carboplatin\" outputclass=\"int-drug\">carboplatin</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  carboplatin  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "29",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Carboplatin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017765",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017765_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"carfilzomib\" outputclass=\"int-drug\">carfilzomib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  carfilzomib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "30",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Carfilzomib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017766",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017766_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"carmustine\" outputclass=\"int-drug\">carmustine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  carmustine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "31",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Carmustine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017767",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017767_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"ceritinib\" outputclass=\"int-drug\">ceritinib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  ceritinib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "32",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ceritinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017768",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017768_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"certolizumab pegol\" outputclass=\"int-drug\">certolizumab pegol</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  certolizumab pegol  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "33",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Certolizumab pegol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017769",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017769_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"chlorambucil\" outputclass=\"int-drug\">chlorambucil</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  chlorambucil  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "34",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Chlorambucil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017770",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017770_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"cisplatin\" outputclass=\"int-drug\">cisplatin</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  cisplatin  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "35",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cisplatin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017771",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017771_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"cladribine\" outputclass=\"int-drug\">cladribine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  cladribine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "36",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cladribine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017772",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017772_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"clavulanate\" outputclass=\"int-drug\">clavulanate</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  clavulanate  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "37",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clavulanate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017773",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017773_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"clofarabine\" outputclass=\"int-drug\">clofarabine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  clofarabine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "38",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clofarabine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017774",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017774_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"crisantaspase\" outputclass=\"int-drug\">crisantaspase</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  crisantaspase  can increase the risk of hepatotoxicity. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017774_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"crisantaspase\" outputclass=\"int-drug\">crisantaspase</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  sulfasalazine  and  crisantaspase  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "39",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Crisantaspase</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017775",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017775_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"cyclophosphamide\" outputclass=\"int-drug\">cyclophosphamide</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  cyclophosphamide  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "40",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cyclophosphamide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017776",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017776_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"cytarabine\" outputclass=\"int-drug\">cytarabine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  cytarabine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "41",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cytarabine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017777",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017777_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"dacarbazine\" outputclass=\"int-drug\">dacarbazine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  dacarbazine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "42",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dacarbazine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017778",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017778_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"dactinomycin\" outputclass=\"int-drug\">dactinomycin</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  dactinomycin  can increase the risk of hepatotoxicity. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017778_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"dactinomycin\" outputclass=\"int-drug\">dactinomycin</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  sulfasalazine  and  dactinomycin  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "43",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dactinomycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017779",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017779_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"dantrolene\" outputclass=\"int-drug\">dantrolene</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  dantrolene  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "44",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dantrolene</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017780",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017780_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"daratumumab\" outputclass=\"int-drug\">daratumumab</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  daratumumab  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "45",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Daratumumab</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017781",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017781_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"darolutamide\" outputclass=\"int-drug\">Darolutamide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Darolutamide   is predicted to   increase   the exposure to   sulfasalazine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "46",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Darolutamide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017782",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017782_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"dasatinib\" outputclass=\"int-drug\">dasatinib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  dasatinib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "47",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dasatinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017783",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017783_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"daunorubicin\" outputclass=\"int-drug\">daunorubicin</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  daunorubicin  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "48",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Daunorubicin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017784",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017784_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"decitabine\" outputclass=\"int-drug\">decitabine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  decitabine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "49",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Decitabine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017785",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017785_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"demeclocycline\" outputclass=\"int-drug\">demeclocycline</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  demeclocycline  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "50",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Demeclocycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017786",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017786_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"dexrazoxane\" outputclass=\"int-drug\">dexrazoxane</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  dexrazoxane  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "51",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dexrazoxane</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017787",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017787_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">Sulfasalazine</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the concentration of</ph> <ph otherprops=\"digoxin\" outputclass=\"int-drug\">digoxin</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor <ph otherprops=\"digoxin\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/digoxin.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP752\">digoxin</xref></ph> concentration</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Sulfasalazine   decreases   the concentration of   digoxin .  Manufacturer advises monitor  digoxin  concentration .    \n\n"
						}
					],
					"hasOrder": "52",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Digoxin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017788",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017788_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"dinutuximab\" outputclass=\"int-drug\">dinutuximab</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  dinutuximab  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "53",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dinutuximab</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017789",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017789_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"docetaxel\" outputclass=\"int-drug\">docetaxel</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  docetaxel  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "54",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Docetaxel</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017790",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017790_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"doxorubicin\" outputclass=\"int-drug\">doxorubicin</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  doxorubicin  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "55",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Doxorubicin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017791",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017791_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"doxycycline\" outputclass=\"int-drug\">doxycycline</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  doxycycline  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "56",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Doxycycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017792",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017792_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"epirubicin\" outputclass=\"int-drug\">epirubicin</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  epirubicin  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "57",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Epirubicin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017793",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017793_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"eribulin\" outputclass=\"int-drug\">eribulin</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  eribulin  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "58",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Eribulin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017794",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017794_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"estramustine\" outputclass=\"int-drug\">estramustine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  estramustine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "59",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Estramustine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017795",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017795_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"etoposide\" outputclass=\"int-drug\">etoposide</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  etoposide  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "60",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Etoposide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017796",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017796_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"flucloxacillin\" outputclass=\"int-drug\">flucloxacillin</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  flucloxacillin  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "61",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Flucloxacillin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017797",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017797_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"fluconazole\" outputclass=\"int-drug\">fluconazole</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  fluconazole  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "62",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fluconazole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017798",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017798_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"fludarabine\" outputclass=\"int-drug\">fludarabine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  fludarabine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "63",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fludarabine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017799",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017799_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"fluorouracil\" outputclass=\"int-drug\">fluorouracil</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  fluorouracil  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "64",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fluorouracil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017800",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017800_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"fluvastatin\" outputclass=\"int-drug\">fluvastatin</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  fluvastatin  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "65",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fluvastatin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017801",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017801_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">Sulfasalazine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"folic acid\" outputclass=\"int-drug\">folic acid</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Sulfasalazine   is predicted to   decrease   the absorption of   folic acid .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "66",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Folic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017802",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017802_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">Sulfasalazine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"folinic acid\" outputclass=\"int-drug\">folinic acid</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Sulfasalazine   is predicted to   decrease   the absorption of   folinic acid .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "67",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Folinic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017803",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017803_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"ganciclovir\" outputclass=\"int-drug\">ganciclovir</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  ganciclovir  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "68",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ganciclovir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017804",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017804_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"gemcitabine\" outputclass=\"int-drug\">gemcitabine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  gemcitabine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "69",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Gemcitabine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017805",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017805_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"gemtuzumab ozogamicin\" outputclass=\"int-drug\">gemtuzumab ozogamicin</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  gemtuzumab ozogamicin  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "70",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Gemtuzumab ozogamicin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017806",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017806_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"golimumab\" outputclass=\"int-drug\">golimumab</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  golimumab  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "71",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Golimumab</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017807",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017807_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"hydroxycarbamide\" outputclass=\"int-drug\">hydroxycarbamide</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  hydroxycarbamide  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "72",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Hydroxycarbamide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017808",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017808_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"ibrutinib\" outputclass=\"int-drug\">ibrutinib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  ibrutinib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "73",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ibrutinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017809",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017809_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"idarubicin\" outputclass=\"int-drug\">idarubicin</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  idarubicin  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "74",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Idarubicin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017810",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017810_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"ifosfamide\" outputclass=\"int-drug\">ifosfamide</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  ifosfamide  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "75",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ifosfamide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017811",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017811_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"imatinib\" outputclass=\"int-drug\">imatinib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  imatinib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "76",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Imatinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017812",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017812_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"infliximab\" outputclass=\"int-drug\">infliximab</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  infliximab  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "77",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Infliximab</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017813",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017813_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"inotuzumab ozogamicin\" outputclass=\"int-drug\">inotuzumab ozogamicin</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  inotuzumab ozogamicin  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "78",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Inotuzumab ozogamicin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017814",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017814_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"ipilimumab\" outputclass=\"int-drug\">ipilimumab</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  ipilimumab  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "79",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ipilimumab</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017815",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017815_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"irinotecan\" outputclass=\"int-drug\">irinotecan</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  irinotecan  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "80",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Irinotecan</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017816",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017816_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"isavuconazole\" outputclass=\"int-drug\">Isavuconazole</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Isavuconazole   is predicted to   increase   the exposure to   sulfasalazine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "81",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Isavuconazole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017817",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017817_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"isoniazid\" outputclass=\"int-drug\">isoniazid</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  isoniazid  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "82",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Isoniazid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017818",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017818_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"itraconazole\" outputclass=\"int-drug\">itraconazole</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  itraconazole  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "83",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Itraconazole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017819",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017819_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"leflunomide\" outputclass=\"int-drug\">leflunomide</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  leflunomide  can increase the risk of hepatotoxicity. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017819_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"leflunomide\" outputclass=\"int-drug\">leflunomide</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  sulfasalazine  and  leflunomide  can increase the risk of myelosuppression. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017819_message_2",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"leflunomide\" outputclass=\"int-drug\">Leflunomide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "3",
							"hasTextContent": "Leflunomide   is predicted to   increase   the exposure to   sulfasalazine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "84",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Leflunomide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017820",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017820_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"lenalidomide\" outputclass=\"int-drug\">lenalidomide</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  lenalidomide  can increase the risk of hepatotoxicity. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017820_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"lenalidomide\" outputclass=\"int-drug\">lenalidomide</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  sulfasalazine  and  lenalidomide  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "85",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lenalidomide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017821",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017821_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">Sulfasalazine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"levofolinic acid\" outputclass=\"int-drug\">levofolinic acid</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Sulfasalazine   is predicted to   decrease   the absorption of   levofolinic acid .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "86",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Levofolinic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017822",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017822_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"lomitapide\" outputclass=\"int-drug\">lomitapide</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  lomitapide  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "87",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lomitapide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017823",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017823_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"lomustine\" outputclass=\"int-drug\">lomustine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  lomustine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "88",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lomustine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017824",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017824_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"lymecycline\" outputclass=\"int-drug\">lymecycline</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  lymecycline  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "89",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lymecycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017825",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017825_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"melphalan\" outputclass=\"int-drug\">melphalan</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  melphalan  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "90",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Melphalan</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017826",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017826_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"mercaptopurine\" outputclass=\"int-drug\">mercaptopurine</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  mercaptopurine  can increase the risk of hepatotoxicity. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017826_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"mercaptopurine\" outputclass=\"int-drug\">mercaptopurine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  sulfasalazine  and  mercaptopurine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "91",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mercaptopurine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017827",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017827_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"methotrexate\" outputclass=\"int-drug\">methotrexate</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  methotrexate  can increase the risk of hepatotoxicity. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017827_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"methotrexate\" outputclass=\"int-drug\">methotrexate</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  sulfasalazine  and  methotrexate  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "92",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Methotrexate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017828",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017828_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"micafungin\" outputclass=\"int-drug\">micafungin</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  micafungin  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "93",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Micafungin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017829",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017829_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"mifamurtide\" outputclass=\"int-drug\">mifamurtide</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  mifamurtide  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "94",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mifamurtide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017830",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017830_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"minocycline\" outputclass=\"int-drug\">minocycline</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  minocycline  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "95",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Minocycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017831",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017831_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"mitomycin\" outputclass=\"int-drug\">mitomycin</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  mitomycin  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "96",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mitomycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017832",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017832_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"mitotane\" outputclass=\"int-drug\">mitotane</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  mitotane  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "97",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mitotane</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017833",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017833_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"mitoxantrone\" outputclass=\"int-drug\">mitoxantrone</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  mitoxantrone  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "98",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mitoxantrone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017834",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017834_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"mogamulizumab\" outputclass=\"int-drug\">mogamulizumab</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  mogamulizumab  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "99",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mogamulizumab</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017835",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017835_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"nelarabine\" outputclass=\"int-drug\">nelarabine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  nelarabine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "100",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nelarabine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017836",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017836_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"neratinib\" outputclass=\"int-drug\">neratinib</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  neratinib  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "101",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Neratinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017837",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017837_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"nilotinib\" outputclass=\"int-drug\">nilotinib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  nilotinib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "102",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nilotinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017838",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017838_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"niraparib\" outputclass=\"int-drug\">niraparib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  niraparib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "103",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Niraparib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017839",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017839_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"nivolumab\" outputclass=\"int-drug\">nivolumab</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  nivolumab  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "104",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nivolumab</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017840",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017840_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"obinutuzumab\" outputclass=\"int-drug\">obinutuzumab</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  obinutuzumab  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "105",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Obinutuzumab</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017841",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017841_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"olaparib\" outputclass=\"int-drug\">olaparib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  olaparib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "106",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Olaparib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017842",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017842_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"oxaliplatin\" outputclass=\"int-drug\">oxaliplatin</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  oxaliplatin  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "107",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Oxaliplatin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017843",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017843_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"oxytetracycline\" outputclass=\"int-drug\">oxytetracycline</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  oxytetracycline  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "108",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Oxytetracycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017844",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017844_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"paclitaxel\" outputclass=\"int-drug\">paclitaxel</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  paclitaxel  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "109",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Paclitaxel</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017845",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017845_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"palbociclib\" outputclass=\"int-drug\">palbociclib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  palbociclib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "110",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Palbociclib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017846",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017846_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"panobinostat\" outputclass=\"int-drug\">panobinostat</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  panobinostat  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "111",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Panobinostat</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017847",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017847_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"paracetamol\" outputclass=\"int-drug\">paracetamol</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  paracetamol  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "112",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Paracetamol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017848",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017848_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"pegaspargase\" outputclass=\"int-drug\">pegaspargase</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  pegaspargase  can increase the risk of hepatotoxicity. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017848_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"pegaspargase\" outputclass=\"int-drug\">pegaspargase</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  sulfasalazine  and  pegaspargase  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "113",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pegaspargase</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017849",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017849_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"peginterferon alfa\" outputclass=\"int-drug\">peginterferon alfa</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  peginterferon alfa  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "114",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Peginterferon alfa</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017850",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017850_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"pembrolizumab\" outputclass=\"int-drug\">pembrolizumab</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  pembrolizumab  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "115",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pembrolizumab</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017851",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017851_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"pemetrexed\" outputclass=\"int-drug\">pemetrexed</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  pemetrexed  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "116",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pemetrexed</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017852",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017852_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"pentostatin\" outputclass=\"int-drug\">pentostatin</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  pentostatin  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "117",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pentostatin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017853",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017853_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"pixantrone\" outputclass=\"int-drug\">pixantrone</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  pixantrone  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "118",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pixantrone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017854",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017854_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"pomalidomide\" outputclass=\"int-drug\">pomalidomide</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  pomalidomide  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "119",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pomalidomide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017855",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017855_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"pravastatin\" outputclass=\"int-drug\">pravastatin</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  pravastatin  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "120",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pravastatin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017856",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017856_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"procarbazine\" outputclass=\"int-drug\">procarbazine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  procarbazine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "121",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Procarbazine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017857",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017857_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"raltitrexed\" outputclass=\"int-drug\">raltitrexed</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  raltitrexed  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "122",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Raltitrexed</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017858",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017858_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"ramucirumab\" outputclass=\"int-drug\">ramucirumab</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  ramucirumab  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "123",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ramucirumab</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017859",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017859_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"regorafenib\" outputclass=\"int-drug\">regorafenib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  regorafenib  can increase the risk of myelosuppression. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017859_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"regorafenib\" outputclass=\"int-drug\">Regorafenib</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Regorafenib   is predicted to   increase   the exposure to   sulfasalazine .  Manufacturer advises monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "124",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Regorafenib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017860",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017860_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"ribociclib\" outputclass=\"int-drug\">ribociclib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  ribociclib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "125",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ribociclib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017861",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017861_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"rituximab\" outputclass=\"int-drug\">rituximab</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  rituximab  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "126",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Rituximab</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017862",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017862_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"ropeginterferon alfa\" outputclass=\"int-drug\">ropeginterferon alfa</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  ropeginterferon alfa  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "127",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ropeginterferon alfa</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017863",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017863_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"rosuvastatin\" outputclass=\"int-drug\">rosuvastatin</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  rosuvastatin  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "128",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Rosuvastatin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017864",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017864_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"roxadustat\" outputclass=\"int-drug\">Roxadustat</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor adverse effects and adjust dose</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Roxadustat   might   increase   the exposure to   sulfasalazine .  Manufacturer advises monitor adverse effects and adjust dose .    \n\n"
						}
					],
					"hasOrder": "129",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Roxadustat</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017865",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017865_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"rucaparib\" outputclass=\"int-drug\">rucaparib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  rucaparib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "130",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Rucaparib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017866",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017866_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"ruxolitinib\" outputclass=\"int-drug\">ruxolitinib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  ruxolitinib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "131",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ruxolitinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017867",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017867_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"simvastatin\" outputclass=\"int-drug\">simvastatin</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  simvastatin  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "132",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Simvastatin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017868",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017868_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"sorafenib\" outputclass=\"int-drug\">sorafenib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  sorafenib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "133",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sorafenib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017869",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017869_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"sotorasib\" outputclass=\"int-drug\">sotorasib</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  sotorasib  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "134",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sotorasib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017870",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017870_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"streptozocin\" outputclass=\"int-drug\">streptozocin</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  streptozocin  can increase the risk of hepatotoxicity. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017870_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"streptozocin\" outputclass=\"int-drug\">streptozocin</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  sulfasalazine  and  streptozocin  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "135",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Streptozocin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017871",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017871_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"sunitinib\" outputclass=\"int-drug\">sunitinib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  sunitinib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "136",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sunitinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017872",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017872_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"talazoparib\" outputclass=\"int-drug\">talazoparib</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  talazoparib  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "137",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Talazoparib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017873",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017873_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"tedizolid\" outputclass=\"int-drug\">Tedizolid</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Tedizolid   is predicted to   increase   the exposure to   sulfasalazine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "138",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tedizolid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017874",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017874_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"tegafur\" outputclass=\"int-drug\">tegafur</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  tegafur  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "139",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tegafur</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017875",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017875_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"temozolomide\" outputclass=\"int-drug\">temozolomide</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  temozolomide  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "140",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Temozolomide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017876",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017876_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"temsirolimus\" outputclass=\"int-drug\">temsirolimus</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  temsirolimus  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "141",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Temsirolimus</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017877",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017877_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"tepotinib\" outputclass=\"int-drug\">Tepotinib</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Tepotinib   might   increase   the exposure to   sulfasalazine .  Manufacturer advises monitor .    \n\n"
						}
					],
					"hasOrder": "142",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tepotinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017878",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017878_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"teriflunomide\" outputclass=\"int-drug\">teriflunomide</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  teriflunomide  can increase the risk of hepatotoxicity. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017878_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"teriflunomide\" outputclass=\"int-drug\">Teriflunomide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Teriflunomide   is predicted to   increase   the exposure to   sulfasalazine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "143",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Teriflunomide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017879",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017879_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"tetracycline\" outputclass=\"int-drug\">tetracycline</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  tetracycline  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "144",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tetracycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017880",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017880_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"thalidomide\" outputclass=\"int-drug\">thalidomide</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  thalidomide  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "145",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Thalidomide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017881",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017881_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"thiotepa\" outputclass=\"int-drug\">thiotepa</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  thiotepa  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "146",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Thiotepa</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017882",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017882_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"tigecycline\" outputclass=\"int-drug\">tigecycline</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  tigecycline  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "147",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tigecycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017883",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017883_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"tioguanine\" outputclass=\"int-drug\">tioguanine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  tioguanine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "148",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tioguanine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017884",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017884_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"topotecan\" outputclass=\"int-drug\">topotecan</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  topotecan  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "149",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Topotecan</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017885",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017885_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"trabectedin\" outputclass=\"int-drug\">trabectedin</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  trabectedin  can increase the risk of hepatotoxicity. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017885_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"trabectedin\" outputclass=\"int-drug\">trabectedin</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  sulfasalazine  and  trabectedin  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "150",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Trabectedin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017886",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017886_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"trastuzumab\" outputclass=\"int-drug\">trastuzumab</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  trastuzumab  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "151",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Trastuzumab</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017887",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017887_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"trastuzumab deruxtecan\" outputclass=\"int-drug\">trastuzumab deruxtecan</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  trastuzumab deruxtecan  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "152",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Trastuzumab deruxtecan</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017888",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017888_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"trastuzumab emtansine\" outputclass=\"int-drug\">trastuzumab emtansine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  trastuzumab emtansine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "153",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Trastuzumab emtansine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017889",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017889_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"treosulfan\" outputclass=\"int-drug\">treosulfan</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  treosulfan  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "154",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Treosulfan</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017890",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017890_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"valganciclovir\" outputclass=\"int-drug\">valganciclovir</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  valganciclovir  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "155",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Valganciclovir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017891",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017891_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"valproate\" outputclass=\"int-drug\">valproate</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  valproate  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "156",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Valproate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017892",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017892_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"velpatasvir\" outputclass=\"int-drug\">Velpatasvir</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Velpatasvir   is predicted to   increase   the exposure to   sulfasalazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "157",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Velpatasvir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017893",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017893_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"venetoclax\" outputclass=\"int-drug\">Venetoclax</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Venetoclax   is predicted to   increase   the exposure to   sulfasalazine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "158",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Venetoclax</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017894",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017894_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"vinblastine\" outputclass=\"int-drug\">vinblastine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  vinblastine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "159",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Vinblastine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017895",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017895_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"vincristine\" outputclass=\"int-drug\">vincristine</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  vincristine  can increase the risk of hepatotoxicity. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017895_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"vincristine\" outputclass=\"int-drug\">vincristine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  sulfasalazine  and  vincristine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "160",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Vincristine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017896",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017896_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"vindesine\" outputclass=\"int-drug\">vindesine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  vindesine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "161",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Vindesine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017897",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017897_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"vinflunine\" outputclass=\"int-drug\">vinflunine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  vinflunine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "162",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Vinflunine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017898",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017898_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph> and <ph otherprops=\"vinorelbine\" outputclass=\"int-drug\">vinorelbine</ph> can increase the risk of myelosuppression.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  sulfasalazine  and  vinorelbine  can increase the risk of myelosuppression. \n\n"
						}
					],
					"hasOrder": "163",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Vinorelbine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017899",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2#bnf_i1643858017899_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"voxilaprevir\" outputclass=\"int-drug\">Voxilaprevir</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the concentration of</ph> <ph otherprops=\"sulfasalazine\" outputclass=\"int-heading-drug\">sulfasalazine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Voxilaprevir   is predicted to   increase   the concentration of   sulfasalazine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "164",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Voxilaprevir</title>"
					}
				}
			],
			"hasSearchLabel": " Sulfasalazine  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/sulfasalazine-2.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Sulfasalazine </title>"
			},
			"rdfs:label": "sulfasalazine"
		}
	]
}